Member Info for roses

Bill brown, are you inanaco ?

I think advfn do a free one month trial, however they are one of the most expensive. They are better, but not by that amount !

No, no tick up. I think lse is having a few issues again today.

MMS still the same as Friday close 21-21.5

C7, STFL Has been one of the market makers for almost a week now, they appeared on level 2 the day after the rns.

Fair enough, I stand corrected !

Maybe they were higher profile acquisitions?

Morning c7, only directorship changes need to be rns’d.

I can’t think of a single occasion when scancell have rns’d the arrival or departure of an employee.

Looks like an online round table event that anyone could join ?

Can anyone tell me where this rumour of a meeting with az came from as I can find no reference to it anywhere?

We have been down this path before with the grand challenge.

The share holders got hyped up assuming we were in with a chance, and when it didn’t happen the share price tanked.

I think it is a prudent decision by scancell to try and not elevate expectations in regard to CEPI’s decision as it could go either way. And if we don’t end up with any funding and scancell were seen to be giving the shareholders the impression that it would, then I think that the same shareholders would be forming a queue to blame the company for giving them a false hope and the share price would tank again.

Indeed, sar’s been fun. But you don want to hang around too long,

History is a good lesson.

Not explicitly , no.

Although it would be nice

No worries wildforce, I was wondering the same my self !!

As long as I haven’t missed anything. I try to keep up with latest releases.

Thanks bud.

Am I missing something ? The last retweet I can see is yesterday ?

Krafty, the appointment of a broker is mandatory whether it is routine, negative or positive.

It’s just the way the rules are.

If they didn’t rns it yesterday they would have broken the law.

Not sure on that one, I would assume if they have done it for previous trials, they would do it for the next one ?

Mark, anything that is price sensitive has to be rns’d.

Not sure about you, but I would assume that the majority of investors would consider it price sensitive ?

We have had application rns’s in the past.

I’m also pretty sure that the scancell won’t be able to recruit any patients until they get the go ahead from MRHA, so you need to factor in the time to recruit as well.

Also, as long as we don’t have the same situation with the MHRA that we had with the FDA wher they kept asking question or wanting clarifications on certain points with the trial.

I’m sure it would be common practise after evaluation that there will be at least one or two points\questions regarding the trial which I assume the company have 6 weeks to respond and then the mhra have 6 weeks to evaluate ?

I think it would be best to go over scancells history with the last submission, then add maybe another third due to lockdown restrictions and backlogs ?